Optival Health Solutions, a subsidiary of Medplus, received a 3-day suspension order for a drug license on October 14, 2025, which may lead to a potential revenue loss of approximately Rs 0.22 lakhs.
AI Assistant
Medplus Health Services Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.